Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
7.835 EUR | +2.42% | +8.52% | +3.02% |
Mar. 22 | Ontex: one of the top 10 patent applicants in Belgium | CF |
Feb. 08 | Ontex: surrounded after a return to profits in 2023 | CF |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
- The company appears to be poorly valued given its net asset value.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- The company has insufficient levels of profitability.
- The company is in debt and has limited leeway for investment
- With an expected P/E ratio at 635.44 and 7.86 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The company is highly valued given the cash flows generated by its activity.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Personal Products
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+3.02% | 686M | B | ||
-5.18% | 18.8B | A- | ||
-15.15% | 3.66B | C+ | ||
+3.08% | 3.61B | B- | ||
+0.58% | 2.55B | - | C- | |
-17.00% | 1.51B | C- | ||
+9.96% | 990M | - | ||
+1.10% | 826M | - | ||
+16.63% | 413M | - | - | |
-19.22% | 385M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock
- Equities
- Stock Ontex Group NV - Euronext Bruxelles
- Ratings Ontex Group NV